{"transactions":[{"id":4619165,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39493,"kind":"person","name":"BRADLEY WILLIAM","position":1,"cik":"0001177319","reported_name":"BRADLEY WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T20:05:05.000Z","date":"2026-09-14","kind":"purchase","planned":false,"acquired":true,"shares":64516,"price":0.6185,"value":39903.146,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase"}],"balance_after":149138,"source":{"system":"sec-edgar","filing":"0001193125-26-393052","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572616/000119312526393052/ownership.xml","form_type":"4"}},{"id":737981,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":15575,"kind":"person","name":"Royan Ajay","position":1,"cik":"0001875614","reported_name":"Royan Ajay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-15T22:06:50.000Z","date":"2026-06-12","kind":"purchase","planned":false,"acquired":true,"shares":23000,"price":0.852,"value":19596.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase."}],"balance_after":40901,"source":{"system":"sec-edgar","filing":"0001193125-26-271386","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875614/000119312526271386/ownership.xml","form_type":"4"}},{"id":742445,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39493,"kind":"person","name":"BRADLEY WILLIAM","position":1,"cik":"0001177319","reported_name":"BRADLEY WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-11T21:04:39.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":0.7318,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001193125-26-267851","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1177319/000119312526267851/ownership.xml","form_type":"4"}},{"id":742444,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39493,"kind":"person","name":"BRADLEY WILLIAM","position":1,"cik":"0001177319","reported_name":"BRADLEY WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T21:04:39.000Z","date":"2026-06-10","kind":"purchase","planned":false,"acquired":true,"shares":68493,"price":0.7348,"value":50328.6564,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase."}],"balance_after":84622,"source":{"system":"sec-edgar","filing":"0001193125-26-267851","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177319/000119312526267851/ownership.xml","form_type":"4"}},{"id":741979,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39336,"kind":"person","name":"Conaway Samuel","position":1,"cik":"0002007319","reported_name":"Conaway Samuel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-11T21:03:59.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":0.7318,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001193125-26-267849","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007319/000119312526267849/ownership.xml","form_type":"4"}},{"id":741887,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":15575,"kind":"person","name":"Royan Ajay","position":1,"cik":"0001875614","reported_name":"Royan Ajay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-11T21:03:10.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":0.7318,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001193125-26-267847","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875614/000119312526267847/ownership.xml","form_type":"4"}},{"id":741235,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39168,"kind":"person","name":"Thompson Christopher Charles","position":1,"cik":"0002084796","reported_name":"Thompson Christopher Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-11T21:02:50.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":0.7318,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001193125-26-267844","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572616/000119312526267844/ownership.xml","form_type":"4"}},{"id":741234,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":17822,"kind":"person","name":"Elia Marc","position":1,"cik":"0001830496","reported_name":"Elia Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-11T21:02:25.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":0.7318,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001193125-26-267843","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572616/000119312526267843/ownership.xml","form_type":"4"}},{"id":741974,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39333,"kind":"person","name":"Barnes Kelly Ann","position":1,"cik":"0002004138","reported_name":"Barnes Kelly Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-11T21:02:08.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":0.7318,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001193125-26-267842","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2004138/000119312526267842/ownership.xml","form_type":"4"}},{"id":741431,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39207,"kind":"person","name":"MEANWELL CLIVE","position":1,"cik":"0001204787","reported_name":"MEANWELL CLIVE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-11T21:00:44.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":0.7318,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001193125-26-267839","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204787/000119312526267839/ownership.xml","form_type":"4"}},{"id":741233,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":722,"kind":"person","name":"Sheffield Ian","position":1,"cik":"0001594410","reported_name":"Sheffield Ian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-11T21:00:18.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":0.7318,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001193125-26-267838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1572616/000119312526267838/ownership.xml","form_type":"4"}},{"id":741232,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":722,"kind":"person","name":"Sheffield Ian","position":1,"cik":"0001594410","reported_name":"Sheffield Ian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T21:00:18.000Z","date":"2026-06-10","kind":"purchase","planned":false,"acquired":true,"shares":35000,"price":0.7294,"value":25529.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001193125-26-267838","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572616/000119312526267838/ownership.xml","form_type":"4"}},{"id":741692,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-11T20:59:53.000Z","date":"2026-06-10","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":0.7301,"value":18252.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7213 to $0.7324, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 13,812 shares of common stock purchased pursuant to the Issuer's 2024 Employee Stock Purchase Plan (ESPP) on January 30, 2026, at a purchase price of $0.391 per share."}],"balance_after":540557,"source":{"system":"sec-edgar","filing":"0001193125-26-267833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000119312526267833/ownership.xml","form_type":"4"}},{"id":744248,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39964,"kind":"person","name":"Smith Weber Lara","position":1,"cik":"0002105051","reported_name":"Smith Weber Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-09T22:55:02.000Z","date":"2026-06-08","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.6854,"value":13708.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6844 to $0.6896, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001193125-26-264430","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572616/000119312526264430/ownership.xml","form_type":"4"}},{"id":939082,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39964,"kind":"person","name":"Smith Weber Lara","position":1,"cik":"0002105051","reported_name":"Smith Weber Lara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2026-01-14T21:30:03.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":1036800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on January 12, 2027, with the remaining 75% of the underlying shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Company as of each such vesting date."}],"balance_after":1036800,"derivative":{"exercise_price":2,"expiration_date":"2036-01-11","underlying":"Common Stock","underlying_shares":1036800},"source":{"system":"sec-edgar","filing":"0001193125-26-012975","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572616/000119312526012975/ownership.xml","form_type":"4"}},{"id":965029,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-17T23:00:03.000Z","date":"2025-12-15","kind":"grant","planned":false,"acquired":true,"shares":2486302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date."}],"balance_after":2486302,"derivative":{"exercise_price":2.24,"expiration_date":"2035-12-14","underlying":"Common Stock","underlying_shares":2486302},"source":{"system":"sec-edgar","filing":"0001193125-25-323017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000119312525323017/ownership.xml","form_type":"4"}},{"id":965414,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71333,"kind":"person","name":"Toomey Sarah","position":1,"cik":"0002003994","reported_name":"Toomey Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-17T18:00:06.000Z","date":"2025-12-15","kind":"grant","planned":false,"acquired":true,"shares":743913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date."}],"balance_after":743913,"derivative":{"exercise_price":2.24,"expiration_date":"2035-12-14","underlying":"Common Stock","underlying_shares":743913},"source":{"system":"sec-edgar","filing":"0001193125-25-323019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2003994/000119312525323019/ownership.xml","form_type":"4"}},{"id":964832,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Stock Option (right to buy)","published_at":"2025-12-17T18:00:05.000Z","date":"2025-12-15","kind":"grant","planned":false,"acquired":true,"shares":845226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date."}],"balance_after":845226,"derivative":{"exercise_price":2.24,"expiration_date":"2035-12-14","underlying":"Common Stock","underlying_shares":845226},"source":{"system":"sec-edgar","filing":"0001193125-25-323018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000119312525323018/ownership.xml","form_type":"4"}},{"id":977604,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-08T12:05:03.000Z","date":"2025-12-04","kind":"purchase","planned":false,"acquired":true,"shares":10416,"price":1.92,"value":19998.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock were purchased by the Reporting Person from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended."}],"balance_after":501745,"source":{"system":"sec-edgar","filing":"0001193125-25-310558","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000119312525310558/ownership.xml","form_type":"4"}},{"id":1047555,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39168,"kind":"person","name":"Thompson Christopher Charles","position":1,"cik":"0002084796","reported_name":"Thompson Christopher Charles","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-09-05T00:36:12.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was awarded for the Reporting Person's appointment on the Issuer's board of directors pursuant to the Issuer's non-employee compensation policy. The stock option vests in three annual installments beginning on the first anniversary of the grant in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":45000,"derivative":{"exercise_price":0.9767,"expiration_date":"2035-09-01","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000950170-25-113125","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572616/000095017025113125/ownership.xml","form_type":"4"}},{"id":1047554,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":722,"kind":"person","name":"Sheffield Ian","position":1,"cik":"0001594410","reported_name":"Sheffield Ian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-09-05T00:07:54.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was awarded for the Reporting Person's appointment on the Issuer's board of directors pursuant to the Issuer's non-employee compensation policy. The stock option vests in three annual installments beginning on the first anniversary of the grant in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":45000,"derivative":{"exercise_price":0.9767,"expiration_date":"2035-09-01","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000950170-25-113112","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572616/000095017025113112/ownership.xml","form_type":"4"}},{"id":1111464,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":16563,"kind":"person","name":"SCHULMAN AMY W","position":1,"cik":"0001438226","reported_name":"SCHULMAN AMY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-13T20:05:22.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":2.27,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-25-086148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438226/000095017025086148/ownership.xml","form_type":"4"}},{"id":1111055,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":17822,"kind":"person","name":"Elia Marc","position":1,"cik":"0001830496","reported_name":"Elia Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-13T20:05:20.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":2.27,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-25-086154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572616/000095017025086154/ownership.xml","form_type":"4"}},{"id":1111288,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39207,"kind":"person","name":"MEANWELL CLIVE","position":1,"cik":"0001204787","reported_name":"MEANWELL CLIVE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-13T20:05:19.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":2.27,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-25-086153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204787/000095017025086153/ownership.xml","form_type":"4"}},{"id":1112718,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39493,"kind":"person","name":"BRADLEY WILLIAM","position":1,"cik":"0001177319","reported_name":"BRADLEY WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-13T20:05:18.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":2.27,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-25-086152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177319/000095017025086152/ownership.xml","form_type":"4"}},{"id":1112090,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39333,"kind":"person","name":"Barnes Kelly Ann","position":1,"cik":"0002004138","reported_name":"Barnes Kelly Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-13T20:05:16.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":2.27,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-25-086151","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2004138/000095017025086151/ownership.xml","form_type":"4"}},{"id":1111993,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":15575,"kind":"person","name":"Royan Ajay","position":1,"cik":"0001875614","reported_name":"Royan Ajay","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2025-06-13T20:05:15.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":2.27,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-25-086144","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875614/000095017025086144/ownership.xml","form_type":"4"}},{"id":1112092,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39336,"kind":"person","name":"Conaway Samuel","position":1,"cik":"0002007319","reported_name":"Conaway Samuel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-13T20:05:12.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date."}],"balance_after":22500,"derivative":{"exercise_price":2.27,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-25-086149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007319/000095017025086149/ownership.xml","form_type":"4"}},{"id":1200381,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":15575,"kind":"person","name":"Royan Ajay","position":1,"cik":"0001875614","reported_name":"Royan Ajay","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-18T23:57:09.000Z","date":"2025-03-14","kind":"purchase","planned":false,"acquired":true,"shares":17901,"price":1.2837,"value":22979.5137,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from 1.22 to 1.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":17901,"source":{"system":"sec-edgar","filing":"0000950170-25-041633","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875614/000095017025041633/ownership.xml","form_type":"4"}},{"id":1200553,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39333,"kind":"person","name":"Barnes Kelly Ann","position":1,"cik":"0002004138","reported_name":"Barnes Kelly Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-18T20:50:44.000Z","date":"2025-03-14","kind":"purchase","planned":false,"acquired":true,"shares":31000,"price":1.2971,"value":40210.1,"ownership":{"direct":true},"balance_after":31000,"source":{"system":"sec-edgar","filing":"0000950170-25-041324","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2004138/000095017025041324/ownership.xml","form_type":"4"}},{"id":1203651,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":16563,"kind":"person","name":"SCHULMAN AMY W","position":1,"cik":"0001438226","reported_name":"SCHULMAN AMY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-17T21:09:08.000Z","date":"2025-03-13","kind":"purchase","planned":false,"acquired":true,"shares":8550,"price":1.1654,"value":9964.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from 1.165 to 1.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":8550,"source":{"system":"sec-edgar","filing":"0000950170-25-040466","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438226/000095017025040466/ownership.xml","form_type":"4"}},{"id":1205141,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39493,"kind":"person","name":"BRADLEY WILLIAM","position":1,"cik":"0001177319","reported_name":"BRADLEY WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-17T18:57:06.000Z","date":"2025-03-13","kind":"purchase","planned":false,"acquired":true,"shares":16129,"price":1.2622,"value":20358.0238,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.2350 to $1.2900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":16129,"source":{"system":"sec-edgar","filing":"0000950170-25-040139","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177319/000095017025040139/ownership.xml","form_type":"4"}},{"id":1204212,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39336,"kind":"person","name":"Conaway Samuel","position":1,"cik":"0002007319","reported_name":"Conaway Samuel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-17T18:56:37.000Z","date":"2025-03-13","kind":"purchase","planned":false,"acquired":true,"shares":8550,"price":1.1654,"value":9964.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from 1.165 to 1.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":8550,"source":{"system":"sec-edgar","filing":"0000950170-25-040138","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007319/000095017025040138/ownership.xml","form_type":"4"}},{"id":1235795,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T01:59:06.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":261540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Issuer's initial public offering, on February 1, 2024 the Reporting Person was granted, subject to the satisfaction of certain performance criteria, an option to purchase 435,900 shares of common stock to vest in the form of shares of the Issuer's common stock in four substantially equal installments on December 31, 2024 and each of the first three anniversaries thereof. On February 27, 2025, the Issuer's administrator determined that the performance criteria were partially met, resulting in 261,540 shares subject to such option being earned, of which 25% vested on December 31, 2024 and the remaining 75% will vest in substantially equal installments on the first three anniversaries thereof."}],"balance_after":261540,"derivative":{"exercise_price":15,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":261540},"source":{"system":"sec-edgar","filing":"0000950170-25-031260","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000095017025031260/ownership.xml","form_type":"4"}},{"id":1235794,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T01:59:06.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":571491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in equal installments on each of the first four anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date."}],"balance_after":571491,"derivative":{"exercise_price":1.46,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":571491},"source":{"system":"sec-edgar","filing":"0000950170-25-031260","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000095017025031260/ownership.xml","form_type":"4"}},{"id":1236267,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":82576,"kind":"person","name":"Kieffer Timothy","position":1,"cik":"0002004011","reported_name":"Kieffer Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-03T21:02:48.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":35280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Issuer's initial public offering, on February 1, 2024 the Reporting Person was granted, subject to the satisfaction of certain performance criteria, an option to purchase 58,800 shares of common stock to vest in the form of shares of the Issuer's common stock in four substantially equal installments on December 31, 2024 and each of the first three anniversaries thereof. On February 27, 2025, the Issuer's administrator determined that the performance criteria were partially met, resulting in 35,280 shares subject to such option being earned, of which 25% vested on December 31, 2024 and the remaining 75% will vest in substantially equal installments on the first three anniversaries thereof."}],"balance_after":35280,"derivative":{"exercise_price":15,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":35280},"source":{"system":"sec-edgar","filing":"0000950170-25-031269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2004011/000095017025031269/ownership.xml","form_type":"4"}},{"id":1236266,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":82576,"kind":"person","name":"Kieffer Timothy","position":1,"cik":"0002004011","reported_name":"Kieffer Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-03T21:02:48.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":169700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in equal installments on each of the first four anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date."}],"balance_after":169700,"derivative":{"exercise_price":1.46,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":169700},"source":{"system":"sec-edgar","filing":"0000950170-25-031269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2004011/000095017025031269/ownership.xml","form_type":"4"}},{"id":1236270,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71333,"kind":"person","name":"Toomey Sarah","position":1,"cik":"0002003994","reported_name":"Toomey Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-03T21:02:05.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":79380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Issuer's initial public offering, on February 1, 2024 the Reporting Person was granted, subject to the satisfaction of certain performance criteria, an option to purchase 132,300 shares of common stock to vest in the form of shares of the Issuer's common stock in four substantially equal installments on December 31, 2024 and each of the first three anniversaries thereof. On February 27, 2025, the Issuer's administrator determined that the performance criteria were partially met, resulting in 79,380 shares subject to such option being earned, of which 25% vested on December 31, 2024 and the remaining 75% will vest in substantially equal installments on the first three anniversaries thereof."}],"balance_after":79380,"derivative":{"exercise_price":15,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":79380},"source":{"system":"sec-edgar","filing":"0000950170-25-031268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2003994/000095017025031268/ownership.xml","form_type":"4"}},{"id":1236269,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71333,"kind":"person","name":"Toomey Sarah","position":1,"cik":"0002003994","reported_name":"Toomey Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-03T21:02:05.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":166200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in equal installments on each of the first four anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date."}],"balance_after":166200,"derivative":{"exercise_price":1.46,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":166200},"source":{"system":"sec-edgar","filing":"0000950170-25-031268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2003994/000095017025031268/ownership.xml","form_type":"4"}},{"id":1235797,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":82563,"kind":"person","name":"Davidson Lisa","position":1,"cik":"0001667666","reported_name":"Davidson Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-03T21:01:26.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":91500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Issuer's initial public offering, on February 1, 2024 the Reporting Person was granted, subject to the satisfaction of certain performance criteria, an option to purchase 152,500 shares of common stock to vest in the form of shares of the Issuer's common stock in four substantially equal installments on December 31, 2024 and each of the first three anniversaries thereof. On February 27, 2025, the Issuer's administrator determined that the performance criteria were partially met, resulting in 91,500 shares subject to such option being earned, of which 25% vested on December 31, 2024 and the remaining 75% will vest in substantially equal installments on the first three anniversaries thereof."}],"balance_after":91500,"derivative":{"exercise_price":15,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":91500},"source":{"system":"sec-edgar","filing":"0000950170-25-031266","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667666/000095017025031266/ownership.xml","form_type":"4"}},{"id":1235796,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":82563,"kind":"person","name":"Davidson Lisa","position":1,"cik":"0001667666","reported_name":"Davidson Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-03T21:01:26.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":174700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in equal installments on each of the first four anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date."}],"balance_after":174700,"derivative":{"exercise_price":1.46,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":174700},"source":{"system":"sec-edgar","filing":"0000950170-25-031266","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667666/000095017025031266/ownership.xml","form_type":"4"}},{"id":1235595,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Stock Option (right to buy)","published_at":"2025-03-03T20:59:55.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":104400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Issuer's initial public offering, on February 1, 2024 the Reporting Person was granted, subject to the satisfaction of certain performance criteria, an option to purchase 174,000 shares of common stock to vest in the form of shares of the Issuer's common stock in four substantially equal installments on December 31, 2024 and each of the first three anniversaries thereof. On February 27, 2025, the Issuer's administrator determined that the performance criteria were partially met, resulting in 104,400 shares subject to such option being earned, of which 25% vested on December 31, 2024 and the remaining 75% will vest in substantially equal installments on the first three anniversaries thereof."}],"balance_after":104400,"derivative":{"exercise_price":15,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":104400},"source":{"system":"sec-edgar","filing":"0000950170-25-031262","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025031262/ownership.xml","form_type":"4"}},{"id":1235594,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Stock Option (right to buy)","published_at":"2025-03-03T20:59:55.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":179700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in equal installments on each of the first four anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date."}],"balance_after":179700,"derivative":{"exercise_price":1.46,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":179700},"source":{"system":"sec-edgar","filing":"0000950170-25-031262","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025031262/ownership.xml","form_type":"4"}},{"id":1287363,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2025-02-03T23:04:37.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":false,"shares":90972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":11564,"derivative":{"exercise_price":1.7,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":90972},"source":{"system":"sec-edgar","filing":"0000950170-25-012531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000095017025012531/ownership.xml","form_type":"4"}},{"id":1287362,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2025-02-03T23:04:37.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":false,"shares":20948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":102536,"derivative":{"exercise_price":1.7,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":20948},"source":{"system":"sec-edgar","filing":"0000950170-25-012531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000095017025012531/ownership.xml","form_type":"4"}},{"id":1287361,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-03T23:04:37.000Z","date":"2025-01-31","kind":"sale","planned":true,"acquired":false,"shares":90972,"price":1.816,"value":165205.152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents sales pursuant to a Rule 10b5-1 plan that the Reporting Person entered into on September 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.8000 to $1.8800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":491329,"source":{"system":"sec-edgar","filing":"0000950170-25-012531","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000095017025012531/ownership.xml","form_type":"4"}},{"id":1287360,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-03T23:04:37.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":true,"shares":90972,"price":1.7,"value":154652.4,"ownership":{"direct":true},"balance_after":582301,"source":{"system":"sec-edgar","filing":"0000950170-25-012531","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000095017025012531/ownership.xml","form_type":"4"}},{"id":1287359,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-03T23:04:37.000Z","date":"2025-01-30","kind":"sale","planned":true,"acquired":false,"shares":20948,"price":1.9476,"value":40798.3248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents sales pursuant to a Rule 10b5-1 plan that the Reporting Person entered into on September 12, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.9100 to $2.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":491329,"source":{"system":"sec-edgar","filing":"0000950170-25-012531","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000095017025012531/ownership.xml","form_type":"4"}},{"id":1287358,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-03T23:04:37.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":true,"shares":20948,"price":1.7,"value":35611.6,"ownership":{"direct":true},"balance_after":512277,"source":{"system":"sec-edgar","filing":"0000950170-25-012531","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000095017025012531/ownership.xml","form_type":"4"}},{"id":1287243,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Stock Option","published_at":"2025-02-03T18:03:55.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":false,"shares":22346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":17924,"derivative":{"exercise_price":1.7,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":22346},"source":{"system":"sec-edgar","filing":"0000950170-25-012530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025012530/ownership.xml","form_type":"4"}},{"id":1287242,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Stock Option","published_at":"2025-02-03T18:03:55.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":false,"shares":21472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":40270,"derivative":{"exercise_price":1.7,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":21472},"source":{"system":"sec-edgar","filing":"0000950170-25-012530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025012530/ownership.xml","form_type":"4"}},{"id":1287241,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2025-02-03T18:03:55.000Z","date":"2025-01-31","kind":"sale","planned":true,"acquired":false,"shares":22346,"price":1.8108,"value":40464.1368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents sales pursuant to a Rule 10b5-1 plan that the Reporting Person entered into on September 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.8000 to $1.8800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":153544,"source":{"system":"sec-edgar","filing":"0000950170-25-012530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025012530/ownership.xml","form_type":"4"}},{"id":1287240,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2025-02-03T18:03:55.000Z","date":"2025-01-31","kind":"exercise","planned":true,"acquired":true,"shares":22346,"price":1.7,"value":37988.2,"ownership":{"direct":true},"balance_after":175890,"source":{"system":"sec-edgar","filing":"0000950170-25-012530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025012530/ownership.xml","form_type":"4"}},{"id":1287239,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2025-02-03T18:03:55.000Z","date":"2025-01-30","kind":"sale","planned":true,"acquired":false,"shares":21472,"price":1.9468,"value":41801.6896,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents sales pursuant to a Rule 10b5-1 plan that the Reporting Person entered into on September 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.9000 to $2.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":153544,"source":{"system":"sec-edgar","filing":"0000950170-25-012530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025012530/ownership.xml","form_type":"4"}},{"id":1287238,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2025-02-03T18:03:55.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":true,"shares":21472,"price":1.7,"value":36502.4,"ownership":{"direct":true},"balance_after":175016,"source":{"system":"sec-edgar","filing":"0000950170-25-012530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017025012530/ownership.xml","form_type":"4"}},{"id":1366559,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-11-13T23:26:12.000Z","date":"2024-11-10","kind":"exercise","planned":false,"acquired":false,"shares":216924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":216924},"source":{"system":"sec-edgar","filing":"0000950170-24-126560","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000095017024126560/ownership.xml","form_type":"4"}},{"id":1366558,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-13T23:26:12.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":96517,"price":2.4696,"value":238358.3832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold for tax-withholding purposes due upon the vesting of the restricted stock units."}],"balance_after":491329,"source":{"system":"sec-edgar","filing":"0000950170-24-126560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000095017024126560/ownership.xml","form_type":"4"}},{"id":1366557,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-13T23:26:12.000Z","date":"2024-11-10","kind":"exercise","planned":false,"acquired":true,"shares":216924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date."}],"balance_after":587846,"source":{"system":"sec-edgar","filing":"0000950170-24-126560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000095017024126560/ownership.xml","form_type":"4"}},{"id":1366443,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Restricted Stock Unit","published_at":"2024-11-13T18:25:35.000Z","date":"2024-11-10","kind":"exercise","planned":false,"acquired":false,"shares":187257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":187257},"source":{"system":"sec-edgar","filing":"0000950170-24-126558","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024126558/ownership.xml","form_type":"4"}},{"id":1366442,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2024-11-13T18:25:35.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":64197,"price":2.4696,"value":158540.9112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold for tax-withholding purposes due upon the vesting of the restricted stock units."}],"balance_after":153544,"source":{"system":"sec-edgar","filing":"0000950170-24-126558","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024126558/ownership.xml","form_type":"4"}},{"id":1366441,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2024-11-13T18:25:35.000Z","date":"2024-11-10","kind":"exercise","planned":false,"acquired":true,"shares":187257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date."}],"balance_after":217741,"source":{"system":"sec-edgar","filing":"0000950170-24-126558","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024126558/ownership.xml","form_type":"4"}},{"id":1407589,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Stock Option","published_at":"2024-09-13T18:39:14.000Z","date":"2024-09-12","kind":"exercise","planned":false,"acquired":false,"shares":95484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.7,"expiration_date":"2024-11-10","underlying":"Common Stock","underlying_shares":95484},"source":{"system":"sec-edgar","filing":"0000950170-24-106530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024106530/ownership.xml","form_type":"4"}},{"id":1407588,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2024-09-13T18:39:14.000Z","date":"2024-09-12","kind":"sale","planned":false,"acquired":false,"shares":65000,"price":2.8996,"value":188474.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $2.85 to $3.06. The Reporting Person undertakes to provide upon request the Staff of the Securities and Exchange Commission, the Issuer, or any stockholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":30484,"source":{"system":"sec-edgar","filing":"0000950170-24-106530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024106530/ownership.xml","form_type":"4"}},{"id":1407587,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":71300,"kind":"person","name":"Caplan Jay David","position":1,"cik":"0001419217","reported_name":"Caplan Jay David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Chief Product Off."}}],"security":"Common Stock","published_at":"2024-09-13T18:39:14.000Z","date":"2024-09-12","kind":"exercise","planned":false,"acquired":true,"shares":95484,"price":1.7,"value":162322.8,"ownership":{"direct":true},"balance_after":95484,"source":{"system":"sec-edgar","filing":"0000950170-24-106530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419217/000095017024106530/ownership.xml","form_type":"4"}},{"id":1554098,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":92368,"kind":"person","name":"Kimber Adrian","position":1,"cik":"0002016940","reported_name":"Kimber Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2024-04-02T16:20:12.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the underlying shares on April 1, 2025 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":250000,"derivative":{"exercise_price":7.45,"expiration_date":"2034-03-31","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000950170-24-040179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2016940/000095017024040179/ownership.xml","form_type":"4"}},{"id":1653308,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":94498,"kind":"organization","name":"Bessemer Venture Partners VII L.P.","position":1,"cik":"0001534338","reported_name":"Bessemer Venture Partners VII L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94499,"kind":"organization","name":"Bessemer Venture Partners VII Institutional L.P.","position":2,"cik":"0001407577","reported_name":"Bessemer Venture Partners VII Institutional L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94500,"kind":"organization","name":"BVP VII SPECIAL OPPORTUNITY FUND LP","position":3,"cik":"0001459524","reported_name":"BVP VII SPECIAL OPPORTUNITY FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94501,"kind":"organization","name":"Deer VII & Co. L.P.","position":4,"cik":"0001540731","reported_name":"Deer VII & Co. L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94502,"kind":"organization","name":"Deer VII & Co. Ltd.","position":5,"cik":"0001540726","reported_name":"Deer VII & Co. Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2024-02-08T22:44:04.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":352159,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents 112,691 shares of Series E Preferred Stock converted to 52,512 shares of Common Stock held by BVP VII, 49,302 shares of Series E Preferred Stock converted to 22,973 shares of Common Stock held by BVP VII Inst, and 190,166 shares of Series E Preferred Stock converted to 88,614 shares of Common Stock held by BVP VII SOF."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Represents 112,691 shares of Series E Preferred Stock converted to 52,512 shares of Common Stock held by BVP VII, 49,302 shares of Series E Preferred Stock converted to 22,973 shares of Common Stock held by BVP VII Inst, and 190,166 shares of Series E Preferred Stock converted to 88,614 shares of Common Stock held by BVP VII SOF."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Deer VII & Co. Ltd. (\"Deer Ltd.\") is the general partner of Deer VII & Co. L.P. (\"Deer L.P.\"), which is the general partner of the BVP VII Funds. Deer Ltd. and Deer L.P. disclaim beneficial ownership of the securities held by the BVP VII Funds, and this report shall not be deemed an admission that Deer Ltd. and Deer L.P. are the beneficial owners of such securities, except to the extent of their pecuniary interest therein, if any, by virtue of their direct and indirect general partner interests in the BVP VII Funds."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":164099},"source":{"system":"sec-edgar","filing":"0001415889-24-003067","document":"form4-02082024_100252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1459524/000141588924003067/form4-02082024_100252.xml","form_type":"4"}},{"id":1653307,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":94498,"kind":"organization","name":"Bessemer Venture Partners VII L.P.","position":1,"cik":"0001534338","reported_name":"Bessemer Venture Partners VII L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94499,"kind":"organization","name":"Bessemer Venture Partners VII Institutional L.P.","position":2,"cik":"0001407577","reported_name":"Bessemer Venture Partners VII Institutional L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94500,"kind":"organization","name":"BVP VII SPECIAL OPPORTUNITY FUND LP","position":3,"cik":"0001459524","reported_name":"BVP VII SPECIAL OPPORTUNITY FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94501,"kind":"organization","name":"Deer VII & Co. L.P.","position":4,"cik":"0001540731","reported_name":"Deer VII & Co. L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94502,"kind":"organization","name":"Deer VII & Co. Ltd.","position":5,"cik":"0001540726","reported_name":"Deer VII & Co. Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2024-02-08T22:44:04.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":908998,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents 290,879 shares of Series D Preferred Stock converted to 135,544 shares of Common Stock held by BVP VII, 127,260 shares of Series D Preferred Stock converted to 59,301 shares of Common Stock held by BVP VII Inst, and 490,859 shares of Series D Preferred Stock converted to 228,732 shares of Common Stock held by BVP VII SOF."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Represents 290,879 shares of Series D Preferred Stock converted to 135,544 shares of Common Stock held by BVP VII, 127,260 shares of Series D Preferred Stock converted to 59,301 shares of Common Stock held by BVP VII Inst, and 490,859 shares of Series D Preferred Stock converted to 228,732 shares of Common Stock held by BVP VII SOF."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Deer VII & Co. Ltd. (\"Deer Ltd.\") is the general partner of Deer VII & Co. L.P. (\"Deer L.P.\"), which is the general partner of the BVP VII Funds. Deer Ltd. and Deer L.P. disclaim beneficial ownership of the securities held by the BVP VII Funds, and this report shall not be deemed an admission that Deer Ltd. and Deer L.P. are the beneficial owners of such securities, except to the extent of their pecuniary interest therein, if any, by virtue of their direct and indirect general partner interests in the BVP VII Funds."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":423577},"source":{"system":"sec-edgar","filing":"0001415889-24-003067","document":"form4-02082024_100252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1459524/000141588924003067/form4-02082024_100252.xml","form_type":"4"}},{"id":1653306,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":94498,"kind":"organization","name":"Bessemer Venture Partners VII L.P.","position":1,"cik":"0001534338","reported_name":"Bessemer Venture Partners VII L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94499,"kind":"organization","name":"Bessemer Venture Partners VII Institutional L.P.","position":2,"cik":"0001407577","reported_name":"Bessemer Venture Partners VII Institutional L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94500,"kind":"organization","name":"BVP VII SPECIAL OPPORTUNITY FUND LP","position":3,"cik":"0001459524","reported_name":"BVP VII SPECIAL OPPORTUNITY FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94501,"kind":"organization","name":"Deer VII & Co. L.P.","position":4,"cik":"0001540731","reported_name":"Deer VII & Co. L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94502,"kind":"organization","name":"Deer VII & Co. Ltd.","position":5,"cik":"0001540726","reported_name":"Deer VII & Co. Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-2 Preferred Stock","published_at":"2024-02-08T22:44:04.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1625698,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents 520,223 shares of Series C-2 Preferred Stock converted to 242,415 shares of Common Stock held by BVP VII, 227,598 shares of Series C-2 Preferred Stock converted to 106,056 shares of Common Stock held by BVP VII Inst, and 877,877 shares of Series C-2 Preferred Stock converted to 409,075 shares of Common Stock held by BVP VII SOF."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Represents 520,223 shares of Series C-2 Preferred Stock converted to 242,415 shares of Common Stock held by BVP VII, 227,598 shares of Series C-2 Preferred Stock converted to 106,056 shares of Common Stock held by BVP VII Inst, and 877,877 shares of Series C-2 Preferred Stock converted to 409,075 shares of Common Stock held by BVP VII SOF."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Deer VII & Co. Ltd. (\"Deer Ltd.\") is the general partner of Deer VII & Co. L.P. (\"Deer L.P.\"), which is the general partner of the BVP VII Funds. Deer Ltd. and Deer L.P. disclaim beneficial ownership of the securities held by the BVP VII Funds, and this report shall not be deemed an admission that Deer Ltd. and Deer L.P. are the beneficial owners of such securities, except to the extent of their pecuniary interest therein, if any, by virtue of their direct and indirect general partner interests in the BVP VII Funds."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":757546},"source":{"system":"sec-edgar","filing":"0001415889-24-003067","document":"form4-02082024_100252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1459524/000141588924003067/form4-02082024_100252.xml","form_type":"4"}},{"id":1653305,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":94498,"kind":"organization","name":"Bessemer Venture Partners VII L.P.","position":1,"cik":"0001534338","reported_name":"Bessemer Venture Partners VII L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94499,"kind":"organization","name":"Bessemer Venture Partners VII Institutional L.P.","position":2,"cik":"0001407577","reported_name":"Bessemer Venture Partners VII Institutional L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94500,"kind":"organization","name":"BVP VII SPECIAL OPPORTUNITY FUND LP","position":3,"cik":"0001459524","reported_name":"BVP VII SPECIAL OPPORTUNITY FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94501,"kind":"organization","name":"Deer VII & Co. L.P.","position":4,"cik":"0001540731","reported_name":"Deer VII & Co. L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94502,"kind":"organization","name":"Deer VII & Co. Ltd.","position":5,"cik":"0001540726","reported_name":"Deer VII & Co. Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2024-02-08T22:44:04.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":2236537,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents 715,692 shares of Series C-1 Preferred Stock converted to 333,500 shares of Common Stock held by BVP VII, 313,115 shares of Series C-1 Preferred Stock converted to 145,906 shares of Common Stock held by BVP VII Inst, and 1,207,730 shares of Series C-1 Preferred Stock converted to 562,781 shares of Common Stock held by BVP VII SOF."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Represents 715,692 shares of Series C-1 Preferred Stock converted to 333,500 shares of Common Stock held by BVP VII, 313,115 shares of Series C-1 Preferred Stock converted to 145,906 shares of Common Stock held by BVP VII Inst, and 1,207,730 shares of Series C-1 Preferred Stock converted to 562,781 shares of Common Stock held by BVP VII SOF."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Deer VII & Co. Ltd. (\"Deer Ltd.\") is the general partner of Deer VII & Co. L.P. (\"Deer L.P.\"), which is the general partner of the BVP VII Funds. Deer Ltd. and Deer L.P. disclaim beneficial ownership of the securities held by the BVP VII Funds, and this report shall not be deemed an admission that Deer Ltd. and Deer L.P. are the beneficial owners of such securities, except to the extent of their pecuniary interest therein, if any, by virtue of their direct and indirect general partner interests in the BVP VII Funds."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1042187},"source":{"system":"sec-edgar","filing":"0001415889-24-003067","document":"form4-02082024_100252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1459524/000141588924003067/form4-02082024_100252.xml","form_type":"4"}},{"id":1653304,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":94498,"kind":"organization","name":"Bessemer Venture Partners VII L.P.","position":1,"cik":"0001534338","reported_name":"Bessemer Venture Partners VII L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94499,"kind":"organization","name":"Bessemer Venture Partners VII Institutional L.P.","position":2,"cik":"0001407577","reported_name":"Bessemer Venture Partners VII Institutional L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94500,"kind":"organization","name":"BVP VII SPECIAL OPPORTUNITY FUND LP","position":3,"cik":"0001459524","reported_name":"BVP VII SPECIAL OPPORTUNITY FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94501,"kind":"organization","name":"Deer VII & Co. L.P.","position":4,"cik":"0001540731","reported_name":"Deer VII & Co. L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94502,"kind":"organization","name":"Deer VII & Co. Ltd.","position":5,"cik":"0001540726","reported_name":"Deer VII & Co. Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-02-08T22:44:04.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":3161709,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 1,011,748 shares of Series B Preferred Stock converted to 471,457 shares of Common Stock held by BVP VII, 442,639 shares of Series B Preferred Stock converted to 206,262 shares of Common Stock held by BVP VII Inst, and 1,707,322 shares of Series B Preferred Stock converted to 795,583 shares of Common Stock held by BVP VII SOF."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Represents 1,011,748 shares of Series B Preferred Stock converted to 471,457 shares of Common Stock held by BVP VII, 442,639 shares of Series B Preferred Stock converted to 206,262 shares of Common Stock held by BVP VII Inst, and 1,707,322 shares of Series B Preferred Stock converted to 795,583 shares of Common Stock held by BVP VII SOF."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Deer VII & Co. Ltd. (\"Deer Ltd.\") is the general partner of Deer VII & Co. L.P. (\"Deer L.P.\"), which is the general partner of the BVP VII Funds. Deer Ltd. and Deer L.P. disclaim beneficial ownership of the securities held by the BVP VII Funds, and this report shall not be deemed an admission that Deer Ltd. and Deer L.P. are the beneficial owners of such securities, except to the extent of their pecuniary interest therein, if any, by virtue of their direct and indirect general partner interests in the BVP VII Funds."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1473302},"source":{"system":"sec-edgar","filing":"0001415889-24-003067","document":"form4-02082024_100252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1459524/000141588924003067/form4-02082024_100252.xml","form_type":"4"}},{"id":1653303,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":94498,"kind":"organization","name":"Bessemer Venture Partners VII L.P.","position":1,"cik":"0001534338","reported_name":"Bessemer Venture Partners VII L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94499,"kind":"organization","name":"Bessemer Venture Partners VII Institutional L.P.","position":2,"cik":"0001407577","reported_name":"Bessemer Venture Partners VII Institutional L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94500,"kind":"organization","name":"BVP VII SPECIAL OPPORTUNITY FUND LP","position":3,"cik":"0001459524","reported_name":"BVP VII SPECIAL OPPORTUNITY FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94501,"kind":"organization","name":"Deer VII & Co. L.P.","position":4,"cik":"0001540731","reported_name":"Deer VII & Co. L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94502,"kind":"organization","name":"Deer VII & Co. Ltd.","position":5,"cik":"0001540726","reported_name":"Deer VII & Co. Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2024-02-08T22:44:04.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1953271,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 625,047 shares of Series A Preferred Stock converted to 291,261 shares of Common Stock held by Bessemer Venture Partners VII L.P. (\"BVP VII\"), 273,458 shares of Series A Preferred Stock converted to 127,426 shares of Common Stock held by Bessemer Venture Partners VII Institutional L.P. (\"BVP VII Inst\"), and 1,054,766 shares of Series A Preferred Stock converted to 491,503 shares of Common Stock held by BVP VII Special Opportunity Fund L.P. (\"BVP VII SOF\" and together with BVP VII and BVP VII Inst, the \"BVP VII Funds\")."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents 625,047 shares of Series A Preferred Stock converted to 291,261 shares of Common Stock held by Bessemer Venture Partners VII L.P. (\"BVP VII\"), 273,458 shares of Series A Preferred Stock converted to 127,426 shares of Common Stock held by Bessemer Venture Partners VII Institutional L.P. (\"BVP VII Inst\"), and 1,054,766 shares of Series A Preferred Stock converted to 491,503 shares of Common Stock held by BVP VII Special Opportunity Fund L.P. (\"BVP VII SOF\" and together with BVP VII and BVP VII Inst, the \"BVP VII Funds\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Deer VII & Co. Ltd. (\"Deer Ltd.\") is the general partner of Deer VII & Co. L.P. (\"Deer L.P.\"), which is the general partner of the BVP VII Funds. Deer Ltd. and Deer L.P. disclaim beneficial ownership of the securities held by the BVP VII Funds, and this report shall not be deemed an admission that Deer Ltd. and Deer L.P. are the beneficial owners of such securities, except to the extent of their pecuniary interest therein, if any, by virtue of their direct and indirect general partner interests in the BVP VII Funds."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":910190},"source":{"system":"sec-edgar","filing":"0001415889-24-003067","document":"form4-02082024_100252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459524/000141588924003067/form4-02082024_100252.xml","form_type":"4"}},{"id":1653302,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":94498,"kind":"organization","name":"Bessemer Venture Partners VII L.P.","position":1,"cik":"0001534338","reported_name":"Bessemer Venture Partners VII L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94499,"kind":"organization","name":"Bessemer Venture Partners VII Institutional L.P.","position":2,"cik":"0001407577","reported_name":"Bessemer Venture Partners VII Institutional L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94500,"kind":"organization","name":"BVP VII SPECIAL OPPORTUNITY FUND LP","position":3,"cik":"0001459524","reported_name":"BVP VII SPECIAL OPPORTUNITY FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94501,"kind":"organization","name":"Deer VII & Co. L.P.","position":4,"cik":"0001540731","reported_name":"Deer VII & Co. L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94502,"kind":"organization","name":"Deer VII & Co. Ltd.","position":5,"cik":"0001540726","reported_name":"Deer VII & Co. Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-08T22:44:04.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":4770901,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 625,047 shares of Series A Preferred Stock converted to 291,261 shares of Common Stock held by Bessemer Venture Partners VII L.P. (\"BVP VII\"), 273,458 shares of Series A Preferred Stock converted to 127,426 shares of Common Stock held by Bessemer Venture Partners VII Institutional L.P. (\"BVP VII Inst\"), and 1,054,766 shares of Series A Preferred Stock converted to 491,503 shares of Common Stock held by BVP VII Special Opportunity Fund L.P. (\"BVP VII SOF\" and together with BVP VII and BVP VII Inst, the \"BVP VII Funds\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 1,011,748 shares of Series B Preferred Stock converted to 471,457 shares of Common Stock held by BVP VII, 442,639 shares of Series B Preferred Stock converted to 206,262 shares of Common Stock held by BVP VII Inst, and 1,707,322 shares of Series B Preferred Stock converted to 795,583 shares of Common Stock held by BVP VII SOF."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents 715,692 shares of Series C-1 Preferred Stock converted to 333,500 shares of Common Stock held by BVP VII, 313,115 shares of Series C-1 Preferred Stock converted to 145,906 shares of Common Stock held by BVP VII Inst, and 1,207,730 shares of Series C-1 Preferred Stock converted to 562,781 shares of Common Stock held by BVP VII SOF."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents 520,223 shares of Series C-2 Preferred Stock converted to 242,415 shares of Common Stock held by BVP VII, 227,598 shares of Series C-2 Preferred Stock converted to 106,056 shares of Common Stock held by BVP VII Inst, and 877,877 shares of Series C-2 Preferred Stock converted to 409,075 shares of Common Stock held by BVP VII SOF."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents 290,879 shares of Series D Preferred Stock converted to 135,544 shares of Common Stock held by BVP VII, 127,260 shares of Series D Preferred Stock converted to 59,301 shares of Common Stock held by BVP VII Inst, and 490,859 shares of Series D Preferred Stock converted to 228,732 shares of Common Stock held by BVP VII SOF."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents 112,691 shares of Series E Preferred Stock converted to 52,512 shares of Common Stock held by BVP VII, 49,302 shares of Series E Preferred Stock converted to 22,973 shares of Common Stock held by BVP VII Inst, and 190,166 shares of Series E Preferred Stock converted to 88,614 shares of Common Stock held by BVP VII SOF."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's preferred stock was convertible into shares of the Issuer's Common Stock at the holder's election and had no expiration date. The preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"After the reported transaction, BVP VII, BVP VII Inst, and BVP VII SOF own 1,526,689; 667,924; and 2,576,288 shares of common stock, respectively."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Deer VII & Co. Ltd. (\"Deer Ltd.\") is the general partner of Deer VII & Co. L.P. (\"Deer L.P.\"), which is the general partner of the BVP VII Funds. Deer Ltd. and Deer L.P. disclaim beneficial ownership of the securities held by the BVP VII Funds, and this report shall not be deemed an admission that Deer Ltd. and Deer L.P. are the beneficial owners of such securities, except to the extent of their pecuniary interest therein, if any, by virtue of their direct and indirect general partner interests in the BVP VII Funds."}],"balance_after":4770901,"source":{"system":"sec-edgar","filing":"0001415889-24-003067","document":"form4-02082024_100252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459524/000141588924003067/form4-02082024_100252.xml","form_type":"4"}},{"id":1654828,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":3083,"kind":"organization","name":"AMERICAN INTERNATIONAL GROUP, INC.","symbol":"AIG","position":1,"cik":"0000005272","reported_name":"AMERICAN INTERNATIONAL GROUP, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Shares","published_at":"2024-02-08T21:53:03.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":80741,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by National Union Fire Insurance Company of Pittsburgh, Pa."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"National Union Fire Insurance Company of Pittsburgh, Pa. is a wholly owned, indirect subsidiary of American International Group, Inc."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37623},"source":{"system":"sec-edgar","filing":"0001104659-24-012332","document":"tm245543-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/5272/000110465924012332/tm245543-3_4seq1.xml","form_type":"4"}},{"id":1654827,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":3083,"kind":"organization","name":"AMERICAN INTERNATIONAL GROUP, INC.","symbol":"AIG","position":1,"cik":"0000005272","reported_name":"AMERICAN INTERNATIONAL GROUP, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Shares","published_at":"2024-02-08T21:53:03.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":74046,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Lexington Insurance Company"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Lexington Insurance Company is a wholly owned, indirect subsidiary of American International Group, Inc."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":34504},"source":{"system":"sec-edgar","filing":"0001104659-24-012332","document":"tm245543-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/5272/000110465924012332/tm245543-3_4seq1.xml","form_type":"4"}},{"id":1654826,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":3083,"kind":"organization","name":"AMERICAN INTERNATIONAL GROUP, INC.","symbol":"AIG","position":1,"cik":"0000005272","reported_name":"AMERICAN INTERNATIONAL GROUP, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Shares","published_at":"2024-02-08T21:53:03.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":115030,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by American Home Assurance Company"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"American Home Assurance Company is a wholly owned, indirect subsidiary of American International Group, Inc."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":53602},"source":{"system":"sec-edgar","filing":"0001104659-24-012332","document":"tm245543-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/5272/000110465924012332/tm245543-3_4seq1.xml","form_type":"4"}},{"id":1654825,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":3083,"kind":"organization","name":"AMERICAN INTERNATIONAL GROUP, INC.","symbol":"AIG","position":1,"cik":"0000005272","reported_name":"AMERICAN INTERNATIONAL GROUP, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Shares","published_at":"2024-02-08T21:53:03.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":272863,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Corebridge DECO II, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Corebridge DECO II, LLC is an indirect subsidiary of American International Group, Inc."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":127149},"source":{"system":"sec-edgar","filing":"0001104659-24-012332","document":"tm245543-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/5272/000110465924012332/tm245543-3_4seq1.xml","form_type":"4"}},{"id":1654824,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":3083,"kind":"organization","name":"AMERICAN INTERNATIONAL GROUP, INC.","symbol":"AIG","position":1,"cik":"0000005272","reported_name":"AMERICAN INTERNATIONAL GROUP, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Shares","published_at":"2024-02-08T21:53:03.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":346868,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by National Union Fire Insurance Company of Pittsburgh, Pa."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"National Union Fire Insurance Company of Pittsburgh, Pa. is a wholly owned, indirect subsidiary of American International Group, Inc."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":161634},"source":{"system":"sec-edgar","filing":"0001104659-24-012332","document":"tm245543-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/5272/000110465924012332/tm245543-3_4seq1.xml","form_type":"4"}},{"id":1654823,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":3083,"kind":"organization","name":"AMERICAN INTERNATIONAL GROUP, INC.","symbol":"AIG","position":1,"cik":"0000005272","reported_name":"AMERICAN INTERNATIONAL GROUP, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Shares","published_at":"2024-02-08T21:53:03.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":318105,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Lexington Insurance Company"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Lexington Insurance Company is a wholly owned, indirect subsidiary of American International Group, Inc."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":148231},"source":{"system":"sec-edgar","filing":"0001104659-24-012332","document":"tm245543-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/5272/000110465924012332/tm245543-3_4seq1.xml","form_type":"4"}},{"id":1654822,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":3083,"kind":"organization","name":"AMERICAN INTERNATIONAL GROUP, INC.","symbol":"AIG","position":1,"cik":"0000005272","reported_name":"AMERICAN INTERNATIONAL GROUP, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Shares","published_at":"2024-02-08T21:53:03.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":494173,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by American Home Assurance Company"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"American Home Assurance Company is a wholly owned, indirect subsidiary of American International Group, Inc."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":230276},"source":{"system":"sec-edgar","filing":"0001104659-24-012332","document":"tm245543-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/5272/000110465924012332/tm245543-3_4seq1.xml","form_type":"4"}},{"id":1654821,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":3083,"kind":"organization","name":"AMERICAN INTERNATIONAL GROUP, INC.","symbol":"AIG","position":1,"cik":"0000005272","reported_name":"AMERICAN INTERNATIONAL GROUP, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Shares","published_at":"2024-02-08T21:53:03.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1172236,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Corebridge DECO II, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Corebridge DECO II, LLC is an indirect subsidiary of American International Group, Inc."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":546242},"source":{"system":"sec-edgar","filing":"0001104659-24-012332","document":"tm245543-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/5272/000110465924012332/tm245543-3_4seq1.xml","form_type":"4"}},{"id":1654820,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":3083,"kind":"organization","name":"AMERICAN INTERNATIONAL GROUP, INC.","symbol":"AIG","position":1,"cik":"0000005272","reported_name":"AMERICAN INTERNATIONAL GROUP, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-08T21:53:03.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":199257,"ownership":{"direct":false,"nature":"Held by National Union Fire Insurance Company of Pittsburgh, Pa."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"National Union Fire Insurance Company of Pittsburgh, Pa. is a wholly owned, indirect subsidiary of American International Group, Inc."}],"balance_after":199257,"source":{"system":"sec-edgar","filing":"0001104659-24-012332","document":"tm245543-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/5272/000110465924012332/tm245543-3_4seq1.xml","form_type":"4"}},{"id":1654819,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":3083,"kind":"organization","name":"AMERICAN INTERNATIONAL GROUP, INC.","symbol":"AIG","position":1,"cik":"0000005272","reported_name":"AMERICAN INTERNATIONAL GROUP, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-08T21:53:03.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":182735,"ownership":{"direct":false,"nature":"Held by Lexington Insurance Company"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Lexington Insurance Company is a wholly owned, indirect subsidiary of American International Group, Inc."}],"balance_after":182735,"source":{"system":"sec-edgar","filing":"0001104659-24-012332","document":"tm245543-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/5272/000110465924012332/tm245543-3_4seq1.xml","form_type":"4"}},{"id":1654818,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":3083,"kind":"organization","name":"AMERICAN INTERNATIONAL GROUP, INC.","symbol":"AIG","position":1,"cik":"0000005272","reported_name":"AMERICAN INTERNATIONAL GROUP, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-08T21:53:03.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":283878,"ownership":{"direct":false,"nature":"Held by American Home Assurance Company"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"American Home Assurance Company is a wholly owned, indirect subsidiary of American International Group, Inc."}],"balance_after":283878,"source":{"system":"sec-edgar","filing":"0001104659-24-012332","document":"tm245543-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/5272/000110465924012332/tm245543-3_4seq1.xml","form_type":"4"}},{"id":1654817,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":3083,"kind":"organization","name":"AMERICAN INTERNATIONAL GROUP, INC.","symbol":"AIG","position":1,"cik":"0000005272","reported_name":"AMERICAN INTERNATIONAL GROUP, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-08T21:53:03.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":673391,"ownership":{"direct":false,"nature":"Held by Corebridge DECO II, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the \"Preferred Shares\") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Corebridge DECO II, LLC is an indirect subsidiary of American International Group, Inc."}],"balance_after":673391,"source":{"system":"sec-edgar","filing":"0001104659-24-012332","document":"tm245543-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/5272/000110465924012332/tm245543-3_4seq1.xml","form_type":"4"}},{"id":1653212,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39207,"kind":"person","name":"MEANWELL CLIVE","position":1,"cik":"0001204787","reported_name":"MEANWELL CLIVE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series F Preferred Stock","published_at":"2024-02-08T21:40:04.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":596352,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Population Health Capital Partners II, L.P. (\"PHPII\"). The Reporting Person is the Founder of Population Health Partners GP, LLC, the general partner of PHPII, and, as a result, may be deemed to share voting and investment power with respect to the shares held by PHPII. Dr. Meanwell disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":277890},"source":{"system":"sec-edgar","filing":"0000950170-24-012842","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204787/000095017024012842/ownership.xml","form_type":"4"}},{"id":1653211,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39207,"kind":"person","name":"MEANWELL CLIVE","position":1,"cik":"0001204787","reported_name":"MEANWELL CLIVE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-08T21:40:04.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":277890,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Population Health Capital Partners II, L.P. (\"PHPII\"). The Reporting Person is the Founder of Population Health Partners GP, LLC, the general partner of PHPII, and, as a result, may be deemed to share voting and investment power with respect to the shares held by PHPII. Dr. Meanwell disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":277890,"source":{"system":"sec-edgar","filing":"0000950170-24-012842","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204787/000095017024012842/ownership.xml","form_type":"4"}},{"id":1653720,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":15575,"kind":"person","name":"Royan Ajay","position":1,"cik":"0001875614","reported_name":"Royan Ajay","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Stock","published_at":"2024-02-08T21:37:35.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1598225,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held by Mithril II LP (\"II LP\"). Mithril II UGP LLC (\"UGP II\") is the general partner of Mithril II GP LP (\"GP II\"), which is the general partner of II LP, and each of UGP II and GP II may be deemed to have shared voting and dispositive power with respect to the securities held by II LP. The Reporting Person is the sole managing member of UGP II and a member of the investment committee of GP II, and in such capacity may be deemed to have beneficial ownership of the securities held by II LP. The Reporting Person disclaim such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":744746},"source":{"system":"sec-edgar","filing":"0000950170-24-012838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1875614/000095017024012838/ownership.xml","form_type":"4"}},{"id":1653719,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":15575,"kind":"person","name":"Royan Ajay","position":1,"cik":"0001875614","reported_name":"Royan Ajay","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2024-02-08T21:37:35.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":373021,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held by Mithril II LP (\"II LP\"). Mithril II UGP LLC (\"UGP II\") is the general partner of Mithril II GP LP (\"GP II\"), which is the general partner of II LP, and each of UGP II and GP II may be deemed to have shared voting and dispositive power with respect to the securities held by II LP. The Reporting Person is the sole managing member of UGP II and a member of the investment committee of GP II, and in such capacity may be deemed to have beneficial ownership of the securities held by II LP. The Reporting Person disclaim such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":173821},"source":{"system":"sec-edgar","filing":"0000950170-24-012838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1875614/000095017024012838/ownership.xml","form_type":"4"}},{"id":1653718,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":15575,"kind":"person","name":"Royan Ajay","position":1,"cik":"0001875614","reported_name":"Royan Ajay","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2024-02-08T21:37:35.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":545450,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Mithril LP (\"LP\"). Mithril GP LP (\"GP LP\") is the general partner of LP and may be deemed to have shared voting and dispositive power with respect to the securities held by LP. The Reporting Person is the authorized person of GP LP and a member of the investment committee of GP LP, and in such capacity may be deemed to have beneficial ownership of the securities held by LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":254170},"source":{"system":"sec-edgar","filing":"0000950170-24-012838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1875614/000095017024012838/ownership.xml","form_type":"4"}},{"id":1653717,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":15575,"kind":"person","name":"Royan Ajay","position":1,"cik":"0001875614","reported_name":"Royan Ajay","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-2 Preferred Stock","published_at":"2024-02-08T21:37:35.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":6502796,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Mithril LP (\"LP\"). Mithril GP LP (\"GP LP\") is the general partner of LP and may be deemed to have shared voting and dispositive power with respect to the securities held by LP. The Reporting Person is the authorized person of GP LP and a member of the investment committee of GP LP, and in such capacity may be deemed to have beneficial ownership of the securities held by LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3030193},"source":{"system":"sec-edgar","filing":"0000950170-24-012838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1875614/000095017024012838/ownership.xml","form_type":"4"}},{"id":1653716,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":15575,"kind":"person","name":"Royan Ajay","position":1,"cik":"0001875614","reported_name":"Royan Ajay","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2024-02-08T21:37:35.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":4025764,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Mithril LP (\"LP\"). Mithril GP LP (\"GP LP\") is the general partner of LP and may be deemed to have shared voting and dispositive power with respect to the securities held by LP. The Reporting Person is the authorized person of GP LP and a member of the investment committee of GP LP, and in such capacity may be deemed to have beneficial ownership of the securities held by LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1875938},"source":{"system":"sec-edgar","filing":"0000950170-24-012838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1875614/000095017024012838/ownership.xml","form_type":"4"}},{"id":1653715,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":15575,"kind":"person","name":"Royan Ajay","position":1,"cik":"0001875614","reported_name":"Royan Ajay","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-08T21:37:35.000Z","date":"2024-02-06","kind":"purchase","planned":false,"acquired":true,"shares":333333,"price":15,"value":4999995.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held by Mithril II LP (\"II LP\"). Mithril II UGP LLC (\"UGP II\") is the general partner of Mithril II GP LP (\"GP II\"), which is the general partner of II LP, and each of UGP II and GP II may be deemed to have shared voting and dispositive power with respect to the securities held by II LP. The Reporting Person is the sole managing member of UGP II and a member of the investment committee of GP II, and in such capacity may be deemed to have beneficial ownership of the securities held by II LP. The Reporting Person disclaim such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":1251900,"source":{"system":"sec-edgar","filing":"0000950170-24-012838","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875614/000095017024012838/ownership.xml","form_type":"4"}},{"id":1653714,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":15575,"kind":"person","name":"Royan Ajay","position":1,"cik":"0001875614","reported_name":"Royan Ajay","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-08T21:37:35.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":918567,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held by Mithril II LP (\"II LP\"). Mithril II UGP LLC (\"UGP II\") is the general partner of Mithril II GP LP (\"GP II\"), which is the general partner of II LP, and each of UGP II and GP II may be deemed to have shared voting and dispositive power with respect to the securities held by II LP. The Reporting Person is the sole managing member of UGP II and a member of the investment committee of GP II, and in such capacity may be deemed to have beneficial ownership of the securities held by II LP. The Reporting Person disclaim such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":918567,"source":{"system":"sec-edgar","filing":"0000950170-24-012838","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875614/000095017024012838/ownership.xml","form_type":"4"}},{"id":1653713,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":15575,"kind":"person","name":"Royan Ajay","position":1,"cik":"0001875614","reported_name":"Royan Ajay","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-08T21:37:35.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":5160301,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held by Mithril LP (\"LP\"). Mithril GP LP (\"GP LP\") is the general partner of LP and may be deemed to have shared voting and dispositive power with respect to the securities held by LP. The Reporting Person is the authorized person of GP LP and a member of the investment committee of GP LP, and in such capacity may be deemed to have beneficial ownership of the securities held by LP. The Reporting Person disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any."}],"balance_after":5160301,"source":{"system":"sec-edgar","filing":"0000950170-24-012838","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875614/000095017024012838/ownership.xml","form_type":"4"}},{"id":1653460,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Preferred Stock","published_at":"2024-02-08T21:37:14.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":6000,"ownership":{"direct":false,"nature":"By 2016 Irrevocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2795},"source":{"system":"sec-edgar","filing":"0000950170-24-012835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000095017024012835/ownership.xml","form_type":"4"}},{"id":1653459,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Preferred Stock","published_at":"2024-02-08T21:37:14.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":14000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6523},"source":{"system":"sec-edgar","filing":"0000950170-24-012835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000095017024012835/ownership.xml","form_type":"4"}},{"id":1653458,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-08T21:37:14.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":2795,"ownership":{"direct":false,"nature":"By 2016 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."}],"balance_after":292170,"source":{"system":"sec-edgar","filing":"0000950170-24-012835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000095017024012835/ownership.xml","form_type":"4"}},{"id":1653457,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":39275,"kind":"person","name":"Rajagopalan Harith","position":1,"cik":"0001667672","reported_name":"Rajagopalan Harith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-08T21:37:14.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":6523,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."}],"balance_after":663093,"source":{"system":"sec-edgar","filing":"0000950170-24-012835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667672/000095017024012835/ownership.xml","form_type":"4"}},{"id":1653597,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":17822,"kind":"person","name":"Elia Marc","position":1,"cik":"0001830496","reported_name":"Elia Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":45264,"kind":"organization","name":"M28 Capital Management LP","position":2,"cik":"0001807489","reported_name":"M28 Capital Management LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series F Preferred Stock","published_at":"2024-02-08T21:32:39.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":2981763,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed by M28 Capital Management LP (\"M28 Capital Management\") and Marc Elia (\"Mr. Elia\", and each of Mr. Elia and M28 Capital Management, a \"Reporting Person\"). The securities reported herein are held by certain funds and accounts for which M28 Capital Management serves as investment manager. Mr. Elia is the Chief Investment Officer of M28 Capital Management and the Managing Member of M28 Capital Management GP LLC, the general partner of M28 Capital Management. Mr. Elia also serves on the Board of Directors of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1389451},"source":{"system":"sec-edgar","filing":"0000950170-24-012819","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1807489/000095017024012819/ownership.xml","form_type":"4"}},{"id":1653596,"issuer":{"id":6700,"kind":"organization","name":"FRACTYL HEALTH, INC.","symbol":"GUTS"},"owners":[{"id":17822,"kind":"person","name":"Elia Marc","position":1,"cik":"0001830496","reported_name":"Elia Marc","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":45264,"kind":"organization","name":"M28 Capital Management LP","position":2,"cik":"0001807489","reported_name":"M28 Capital Management LP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-08T21:32:39.000Z","date":"2024-02-06","kind":"purchase","planned":false,"acquired":true,"shares":466666,"price":15,"value":6999990.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed by M28 Capital Management LP (\"M28 Capital Management\") and Marc Elia (\"Mr. Elia\", and each of Mr. Elia and M28 Capital Management, a \"Reporting Person\"). The securities reported herein are held by certain funds and accounts for which M28 Capital Management serves as investment manager. Mr. Elia is the Chief Investment Officer of M28 Capital Management and the Managing Member of M28 Capital Management GP LLC, the general partner of M28 Capital Management. Mr. Elia also serves on the Board of Directors of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":1856117,"source":{"system":"sec-edgar","filing":"0000950170-24-012819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807489/000095017024012819/ownership.xml","form_type":"4"}}],"next_cursor":"2024-02-08T21:32:39.000000Z,1653596"}